Hub Group Stock Discussion

Upgrades
• $American Express (AXP.US)$ : Baird Upgrades to Outperform from Neutral - PT $175
• $The AZEK (AZEK.US)$ : BofA Securities Upgrades to Buy from Neutral
• $Capital One Financial (COF.US)$ : Baird Upgrades to Outperform from Neutral - PT $145
• $Fifth Third Bancorp (FITB.US)$ : Baird Upgrades to Outperform from Neutral - PT $44
• $M&T Bank (MTB.US)$ : Baird Upgrades to Outperform from Neutral - PT $200 (from $175)
• $NextEra Energy Partners LP (NEP.US)$ : RBC Cap...

Gainers:
• $GTY Technology (GTYH.US)$ +118.1% (entered into a definitive agreement to be acquired by GI Partners )
• $Finch Therapeutics (FNCH.US)$ +68.33% (announces removal of FDA clinical hold on CP101 IND)
• $Zymeworks (ZYME.US)$ +42.34% (confirms receipt of non-binding proposal from All Blue Falcons for $10.50 per share in cash)
• $Hub Group (HUBG.US)$ +16.3% (earnings reports)
• $Lantheus (LNTH.US)$ +14.2% (earnings reports)
• $Mohawk Industries (MHK.US)$ +13.7% (e...

Upgrades
• $Fortune Brands Home & Security (FBHS.US)$ : BofA Securities Upgrades to Neutral from Underperform - PT $84 (from $74)
• $Forward Air (FWRD.US)$ : Stifel Upgrades to Buy from Hold - PT $136 (from $122)
• $Grocery Outlet (GO.US)$ : BofA Securities Upgrades to Buy from Underperform - PT $37 (from $23)
• $Hub Group (HUBG.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $92 (from $76)
• $IQVIA Holdings (IQV.US)$ : Piper Sandler Upgrades to Overweight...

Upgrades
• $Baker Hughes (BKR.US)$ : HSBC Upgrades to Buy from Hold - PT $38.30
• $United Breweries Co Inc (CCU.US)$ : HSBC Upgrades to Buy from Hold - PT $17
• $Capital City Bank Group (CCBG.US)$ : Piper Sandler Upgrades to Overweight from Neutral - PT $31.50 (from $29)
• $Hub Group (HUBG.US)$ : Susquehanna Upgrades to Positive from Neutral - PT $83 (from $92)
• $Interactive Brokers (IBKR.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $90
• $JB Hunt Transport Services (JBHT.US)$ : Susqueh...

Gainers:
• $Clovis Oncology (CLVS.US)$ +40.6% (Rubraca significantly improves progression-free survival in first-line maintenance treatment in women with ovarian cancer regardless of their biomarker status in phase 3 athena-mono trial)
• $Dare Bioscience (DARE.US)$ +13.61% (Organon and Dar Bioscience have entered into an agreement whereby Organon will license global rights to XACIATO)
• $KULR Technology (KULR.US)$ +9.5% (secured a battery sa...

Upgrades
• $Baker Hughes (BKR.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $43
• $CDW Corp (CDW.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $214 (from $201)
• $Core & Main (CNM.US)$ : Barclays Upgrades to Overweight from Equalweight - PT $34 (from $32)
• $Five Below (FIVE.US)$ : Citigroup Upgrades to Buy from Neutral - PT $205 (from $176)
• $Vector (VGR.US)$ : Barclays Uprages to Overweight from Equal Weight - PT $16 (from ...